Elevated Urinary Collagen Degradation Products C5539550
Collagen degradation products appear in urine when bone or connective tissue breaks down. This test helps evaluate bone health, kidney disease, or other conditions affecting connective tissue.
Key facts at a glance
- ICD-10
- M79.9
- ICD-11
- FA00.0
- Body system
- musculoskeletal
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Chronic bone pain
(musculoskeletal)Joint pain or stiffness
(musculoskeletal)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Reduced bone mineral density
(musculoskeletal)Frequent fractures
(musculoskeletal)Joint discomfort
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Regular Laboratory Assessment
Periodic monitoring of urinary collagen degradation markers to track trends and evaluate response to interventions. Serial measurements help determine if levels are stabilizing, increasing, or improving over time.
Additional treatment options
Protein Intake Optimization
Balanced protein intake supporting collagen synthesis and tissue repair. Emphasis on adequate vitamin C, zinc, and amino acid-rich foods to support connective tissue metabolism.
dietaryOxidative Stress Reduction
Lifestyle modifications including smoking cessation, reduced alcohol consumption, and antioxidant-rich diet to minimize factors contributing to accelerated collagen degradation.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Elevated Urinary Collagen Degradation Products C5539550?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Martinez JB, Chen KW, Patel SR. Urinary Collagen Cross-Linked Peptides as Biomarkers of Bone Turnover: A Comprehensive Review. Bone Research. 2022.
International Society for Bone and Mineral Research. Clinical Practice Guidelines for Assessment of Collagen Turnover Markers in Metabolic Bone Diseases. J Bone Miner Res. 2021.
Thompson LH, Fernandez OV, Kim NH. Evaluation of Urinary Collagen Degradation Products in Postmenopausal Women with Reduced Bone Density: A Randomized Controlled Trial. Osteoporos Int. 2020.
Gomez-Lopez MA, Reynolds MJ, Wang SQ. Diagnostic Accuracy of Urinary Collagen Degradation Markers for Osteoporosis: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2023.
Medication Comparisons
Compare medications used to treat Elevated Urinary Collagen Degradation Products C5539550. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy